![Sample our Physical Sciences journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/110819/TOC-Subject-Sample-2021-Physical-Sciences.jpg"})
Abstract
6,7-Difluoro- 1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo-3-quinilinecarboxylic acid (Abbott-72931) and related compounds are determined by high performance liquid chromatography (HPLC). A two-part assay procedure quantitates both the drug substance and the related compounds. The chromatography used is based on a Bakerbond® C-4 column with a 0.04 M citrate buffer (pH 4.4) eluent modified with THF. Detection is at 254 nm. Quantitation of Abbott-72931 is achieved using an external standard method and an Abbott-72931 reference standard. An isocratic HPLC system is used with a 75% buffer/25% THF eluent. Assay precision (RSD values) for two lots of Abbott-72931 ranged from ± 0.66% to ± 0.97%. Quantitation of related compounds in Abbott-72931 is achieved by an external standard method using the same chromatography, with gradient elution to remove the more strongly retained impurities from the column. Unhydrolyzed Abbott-72931 ethyl ester is quantitated using an Abbott-72931 ethyl ester reference standard. Other compounds are quantitated versus the Abbott-72931 reference standard.Assay precision of related compounds determined in two lots of Abbott-72931 at levels of 0.04% to 1.0% ranged from ± 58% to ± 6.8%. Detector response for Abbott-72931 and Abbott-72931 ethyl ester is linear to at least 25.4 and 9.9 Mg/mL, respectively (correlation coefficients > 0.999, essentially intersecting the origin). Recovery of known related compounds of Abbott-72931 ranged from 94.4 to 107.5% when added to the drug substance at levels of 0.2% to 2.0%.